• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022January

Month: January 2022

Forex News

Canadian Inflation Rate 4.8% as Expected

January 19, 2022 admin 0

Core Inflation Rate = 4% vs 3.5% (Estimate) Inflation Rate YoY = 4.8% vs 4.8 (Estimate) Canadian CPI has arguably become one of the most intriguing data points of 2022 thus far, not far behind […]

Stock News

Bank of America profit beats estimates on loan growth, M&A boost By Reuters

January 19, 2022 admin 0

© Reuters. FILE PHOTO: A Bank of America logo is pictured in the Manhattan borough of New York City, New York, U.S., January 30, 2019. REUTERS/Carlo Allegri (Reuters) -Bank of America Corp reported a better-than-expected […]

Forex News

Boris Johnson Risks Facing Vote of No-Confidence

January 19, 2022 admin 0

GBPUSD Analysis and Talking Points: GBP So Far Unfazed by Rising Political Uncertainty UK PM Johnson’s Tenure Hinges on Sue Gray’s Investigation See our quarterly GBP forecast to learn what will drive prices through Q1 […]

Posts navigation

« 1 … 150 151 152 … 365 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • AAXJ ETF: This Could Be A Fund To Really Get Behind
    January 14, 2023 0
  • Asian Stocks Up Over Positive U.S. Data, Positive Omicron Signs By Investing.com
    December 23, 2021 0
  • Barclays starts Tesla at Overweight, prefers General Motors over Ford By Investing.com
    February 15, 2023 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.